nach oben

Anästhesie Nachrichten

Erschienen in:

21.10.2022 | Freies Thema

Herzfrequenzkontrolle im Schock

verfasst von: Dr. med. Henning Lemm, Prof. Dr. med. Michael Buerke

Erschienen in: Anästhesie Nachrichten | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Auszug

Das Herzminutenvolumen (HZV) stellt das Produkt von Schlagvolumen (SV) und Herzfrequenz (HR) dar. Aufgrund der physiologisch festgelegten relativ fixen Dauer der kardialen Systole ändert sich die Dauer der Diastole negativ proportional zur Herzfrequenz. Die für die Füllung des linken Ventrikels vorhandene Zeit sinkt somit mit steigender Herzfrequenz (Abb. 1). …

Vorheriger Artikel Mitgefühl reanimiert Ärzt*innen und Pfleger*innen

Nächster Artikel Nosokomiale Pneumonien und beatmungsassoziierte Krankenhauserreger

Soma J, Aakhus S, Dahl K, Slørdahl S, Wiseth R, Widerøe TE (1996) Hemodynamics in white coat hypertension compared to ambulatory hypertension and normotension. Am J Hypertens 9:1090–1098CrossRefPubMed

Pierdomenico SD, Bucci A, Lapenna D, Cuccurullo F, Mezzetti A (2001) Clinic and ambulatory heart rate in sustained and white-coat hypertension. Blood Press Monit 6:239–244CrossRefPubMed

Halliwill JR (2001) Mechanisms and clinical implications of post-exercise hypotension in humans. Exerc Sport Sci Rev 29:65–70PubMed

Izzo JL, Anwar MA, Elango K, Ahmed R, Osmond P (2019) Decoupling of heart rate and blood pressure: hemodynamic counter-regulatory mechanisms and their implications. Artery Res 25:87–94CrossRef

Bosch NA, Cimini J, Walkey AJ (2018) Atrial fibrillation in the ICU. Chest 154:1424–1434CrossRefPubMedPubMedCentral

Berk JL, Hagen JF, Maly G, Koo R (1972) The treatment of shock with beta adrenergic blockade. Arch Surg 104:46–51CrossRefPubMed

Benedict CR, Rose JA (1992) Arterial norepinephrine changes in patients with septic shock. Circ Shock 38:165–172PubMed

Sander O, Welters ID, Foëx P, Sear JW (2005) Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 33:81–88 (discussion 241–242)CrossRefPubMed

Schmittinger CA, Torgersen C, Luckner G, Schröder DCH, Lorenz I, Dünser MW (2012) Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 38:950–958CrossRefPubMed

10.

Morelli A, Ertmer C, Westphal M et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683–1691CrossRefPubMed

11.

Fuchs C, Wauschkuhn S, Scheer C, Vollmer M, Meissner K, Kuhn S‑O, Hahnenkamp K, Morelli A, Gründling M, Rehberg S (2017) Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth 119:616–625CrossRefPubMed

12.

Hennen R, Friedrich I, Hoyer D et al (2008) Autonome Dysfunktion und Betablocker beim Multiorgandysfunktionssyndrom. Dtsch Med Wochenschr 133:2500–2504CrossRefPubMed

13.

Schmidt H, Müller-Werdan U, Hoffmann T et al (2006) Attenuated autonomic function in multiple organ dysfunction syndrome across three age groups. Biomed Tech 51:264–267CrossRef

14.

Schmidt H, Lotze U, Ghanem A et al (2014) Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndrome. J Crit Care 29:367–373CrossRefPubMed

15.

Domanovits H, Wolzt M, Stix G (2018) Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting. Eur Heart J Suppl 20:A1–A3CrossRefPubMedPubMedCentral

16.

Matsuda N, Nishida O, Taniguchi T et al (2020) Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J‑Land 3S randomised controlled study. EClinicalMedicine 28:100571CrossRefPubMedPubMedCentral

17.

Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N (2020) Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med 8:863–872CrossRefPubMed

18.

Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, Nishida O (2021) Effect of ultrashort-acting β‑blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest 159:2289–2300CrossRefPubMed

19.

Plosker GL (2013) Landiolol: a review of its use in Intraoperative and postoperative tachyarrhythmias. Drugs 73:959–977CrossRefPubMed

20.

Levy B, Fritz C, Piona C, Duarte K, Morelli A, Guerci P, Kimmoun A, Girerd N (2021) Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study. Crit Care 25:21CrossRefPubMedPubMedCentral

21.

Hasegawa D, Sato R, Nishida O (2021) β1-blocker in sepsis. j intensive care 9:39CrossRefPubMedPubMedCentral

22.

Bosch NA, Rucci JM, Massaro JM, Winter MR, Quinn EK, Chon KH, McManus DD, Walkey AJ (2021) Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation. Chest 159:1452–1459CrossRefPubMed

23.

Izco PM, Castejón B, Piedras MJ, Zamorano JL, Sanmartín M, Zaragoza C (2017) Effects of Ivabradine on heart rate and Hemodynamic parameters in a swine model of cardiogenic shock. Rev Esp Cardiol (Engl Ed) 70:1139–1141

24.

Nuding S, Schröder J, Presek P, Wienke A, Müller-Werdan U, Ebelt H, Werdan K (2018) Reducing elevated heart rates in patients with multiple organ dysfunction syndrome with the if (funny channel current) inhibitor Ivabradine. Shock 49:402–411CrossRefPubMed

25.

Barillà F, Pannarale G, Torromeo C et al (2016) Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study. Clin Drug Investig 36:849–856CrossRefPubMed

26.

Werdan K, Boeken U, Briegel MJ et al (2021) Short version of the 2nd edition of the German-Austrian S3 guidelines “Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment”. Anaesthesist 70:42–70CrossRefPubMed

Titel: Herzfrequenzkontrolle im Schock
verfasst von: Dr. med. Henning Lemm
Prof. Dr. med. Michael Buerke
Publikationsdatum: 21.10.2022
Verlag: Springer Vienna
Erschienen in: Anästhesie Nachrichten / Ausgabe 4/2022
Print ISSN: 2617-2127
Elektronische ISSN: 2731-3972
DOI: https://doi.org/10.1007/s44179-022-00098-8

Springer Medizin Österreich

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

AIC-Wissenschaftspreis 2022: 1. Platz

Keine Mortalitätserhöhung aufgrund einer präoperativ chronischen Hypertension

Die endotheliale Glycocalix

Nosokomiale Pneumonien und beatmungsassoziierte Krankenhauserreger

Das Unterdrucklungenödem

Zwischenbilanz